Wieland M, Lederman M M, Kline-King C, Keys T F, Lerner P I, Bass S N, Chmielewski R, Banks V D, Ellner J J
Medicine (Baltimore). 1986 May;65(3):180-9. doi: 10.1097/00005792-198605000-00006.
Ten confirmed cases of left-sided endocarditis due to Pseudomonas aeruginosa were reported in detail and the English literature was reviewed. In recent years, venous access (usually illicit) has been the major predisposing factor to this infection and abuse of pentazocine and tripelennamine has been particularly associated with endocarditis due to this organism. This infection involves previously damaged as well as normal valves. The development of congestive heart failure did not adversely affect the prognosis of this infection. However, the development of azotemia was associated with a greater likelihood of a fatal outcome. In the current series, deaths were due to uncontrolled infection. This often occurred despite inhibitory and bactericidal activity in serum generally considered adequate for treatment of endocarditis. Medical treatment alone rarely produced cure of infection. Our experience with a high frequency of major vessel embolization (4/10) and the improved survival after medical/surgical treatment suggests that prompt valve replacement combined with high doses of an aminoglycoside plus carbenicillin or ticarcillin provide the best opportunity for successful outcome in patients with left-sided endocarditis due to P. aeruginosa.
详细报告了10例由铜绿假单胞菌引起的左侧心内膜炎确诊病例,并对英文文献进行了综述。近年来,静脉通路(通常是非正规的)一直是这种感染的主要诱发因素,而喷他佐辛和曲吡那敏的滥用尤其与这种病原体引起的心内膜炎有关。这种感染累及先前受损以及正常的瓣膜。充血性心力衰竭的发生并未对这种感染的预后产生不利影响。然而,氮质血症的发生与更高的致命结局可能性相关。在当前系列病例中,死亡原因是感染无法控制。尽管血清中的抑制和杀菌活性通常被认为足以治疗心内膜炎,但这种情况仍经常发生。单独的药物治疗很少能治愈感染。我们在大血管栓塞发生率高(4/10)以及药物/手术治疗后生存率提高方面的经验表明,对于由铜绿假单胞菌引起的左侧心内膜炎患者,及时进行瓣膜置换并联合大剂量氨基糖苷类药物加羧苄西林或替卡西林,为取得成功的治疗结果提供了最佳机会。